AAAAAA

   
Results: 1-11 |
Results: 11
Insulin-lowering drugs in polycystic ovary syndrome
Authors: Iuorno, MJ Nestler, JE
Citation: Mj. Iuorno et Je. Nestler, Insulin-lowering drugs in polycystic ovary syndrome, OB GYN CLIN, 28(1), 2001, pp. 153
Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes
Authors: Peppard, HR Iuorno, MJ Marfori, J Nestler, JE
Citation: Hr. Peppard et al., Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes, DIABET CARE, 24(6), 2001, pp. 1050-1052
Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhancesuterine vascularity and blood flow in the polycystic ovary syndrome
Authors: Jakubowicz, DJ Seppala, M Jakubowicz, S Rodriguez-Armas, O Rivas-Santiago, A Koistinen, H Koistinen, R Nestler, JE
Citation: Dj. Jakubowicz et al., Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhancesuterine vascularity and blood flow in the polycystic ovary syndrome, J CLIN END, 86(3), 2001, pp. 1126-1133
Metformin and the polycystic ovary syndrome
Authors: Nestler, JE
Citation: Je. Nestler, Metformin and the polycystic ovary syndrome, J CLIN END, 86(3), 2001, pp. 1430-1430
Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone
Authors: Vandermolen, DT Ratts, VS Evans, WS Stovall, DW Kauma, SW Nestler, JE
Citation: Dt. Vandermolen et al., Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone, FERT STERIL, 75(2), 2001, pp. 310-315
Role of inositolphophoglycan mediators of insulin action in the polycysticovary syndrome
Authors: Nestler, JE Jakubowicz, DJ Iuorno, MJ
Citation: Je. Nestler et al., Role of inositolphophoglycan mediators of insulin action in the polycysticovary syndrome, J PED END M, 13, 2000, pp. 1295-1298
Obesity, insulin, sex steroids and ovulation
Authors: Nestler, JE
Citation: Je. Nestler, Obesity, insulin, sex steroids and ovulation, INT J OBES, 24, 2000, pp. S71-S73
The polycystic ovary syndrome: treatment with insulin sensitizing agents
Authors: Iuorno, MJ Nestler, JE
Citation: Mj. Iuorno et Je. Nestler, The polycystic ovary syndrome: treatment with insulin sensitizing agents, DIABET OB M, 1(3), 1999, pp. 127-136
Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome
Authors: Nestler, JE Jakubowicz, DJ Reamer, P Gunn, RD Allan, G
Citation: Je. Nestler et al., Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome, N ENG J MED, 340(17), 1999, pp. 1314-1320
The effect of deydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life
Authors: Barnhart, KT Freeman, E Grisso, JA Rader, DJ Sammel, M Kapoor, S Nestler, JE
Citation: Kt. Barnhart et al., The effect of deydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life, J CLIN END, 84(11), 1999, pp. 3896-3902
Insulin resistance effects on sex hormones and ovulation in the polycysticovary syndrome
Authors: Nestler, JE
Citation: Je. Nestler, Insulin resistance effects on sex hormones and ovulation in the polycysticovary syndrome, CONT ENDOC, 12, 1999, pp. 347-365
Risultati: 1-11 |